Overview
- 2 public-safe observations are available for this inspection.
- 2 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
6 Jul 2012
21 CFR 111.553
Written procedures - product complaint
Cited by Meredith M Cobb, Ashley Segura
6 Jul 2012
21 CFR 111.570(b)(2)(ii)(F)
Record - product complaint; findings
Cited by Meredith M Cobb, Ashley Segura
Inspected site
XMXymogen Manufacturing, LLCOrlando, United States
Inspection team
MMMeredith M Cobb
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 111.553 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.570(b)(2)(ii)(F) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 2 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere